E-LIB Suche - Ergebnisse für: Jongs, N.

1

POS-202 DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEA..:

Provenzano, M. ; Jongs, N. ; Stefánsson, B.V....
Kidney International Reports. 7 (2022) 2 - p. S86-S87 , 2022

Link: https://doi.org/10.1016/..

2

POS-832 DAPAGLIFLOZIN IN IgA NEPHROPATHY: FINDINGS FROM THE..:

Lambers Heerspink, H. ; Toto, R.D. ; Jongs, N....
Kidney International Reports. 6 (2021) 4 - p. S362 , 2021

Link: https://doi.org/10.1016/..

3

The effects of dapagliflozin on kidney and cardiovascular o..:

Heerspink, J L ; Wheeler, D C ; Vart, P...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

4

POS-831 THE EFFECT OF DAPAGLIFLOZIN IN PATIENTS WITH eGFR <..:

Chertow, G.M. ; Vart, P. ; Jongs, N....
Kidney International Reports. 6 (2021) 4 - p. S361-S362 , 2021

Link: https://doi.org/10.1016/..

5

Passive behavioural monitoring in neuropsychiatric disorder..:

Jongs, N. ; Jagesar, R. ; Koning, I....
European Neuropsychopharmacology. 28 (2018) - p. S87-S88 , 2018

Link: https://doi.org/10.1016/..

6

Omitted Study Rationale and Acknowledgment of Race as a Soc..:

Vart, P ; Jongs, N ; Wheeler, DC...
https://discovery.ucl.ac.uk/id/eprint/10184420/3/Wheeler_Omitted%20Study%20Rationale%20and%20Acknowledgment%20of%20Race%20as%20a%20Social%20Construct_correction_VoR.pdf. , 2023

Link: https://discovery.ucl.ac..

7

Dapagliflozin and new-onset type 2 diabetes in patients wit..:

Rossing, P ; Inzucchi, SE ; Vart, P...
https://discovery.ucl.ac.uk/id/eprint/10140959/1/Wheeler_Dapagliflozin%20and%20the%20Incidence%20of%20T2D_LDE_revised_clean.pdf. , 2022

Link: https://discovery.ucl.ac..

8

Quételet (Body Mass) Index and Effects of Dapagliflozin in ..:

Chertow, GM ; Vart, P ; Jongs, N...
https://discovery.ucl.ac.uk/id/eprint/10141830/1/Diabetes%20Obesity%20Metabolism%20-%202022%20-%20Chertow%20-%20Qu%20telet%20%20Body%20Mass%20%20Index%20and%20Effects%20of%20Dapagliflozin%20in%20CKD.pdf. , 2022

Link: https://discovery.ucl.ac..

9

Effect of dapagliflozin on urinary albumin excretion in pat..:

Jongs, N ; Greene, T ; Chertow, GM...
https://discovery.ucl.ac.uk/id/eprint/10140984/1/Wheeler_DAPA-CKD_UACR%20ms_9AUG2021_clean.pdf. , 2021

Link: https://discovery.ucl.ac..

10

Effects of Dapagliflozin in Patients With Kidney Disease, W..:

McMurray, JJV ; Wheeler, DC ; Stefánsson, BV...
https://discovery.ucl.ac.uk/id/eprint/10135686/1/1-s2.0-S2213177921003346-main.pdf. , 2021

Link: https://discovery.ucl.ac..

11

Effect of dapagliflozin on the rate of decline in kidney fu..:

Heerspink, HJL ; Jongs, N ; Chertow, GM...
https://discovery.ucl.ac.uk/id/eprint/10140985/1/Wheeler_DAPA-CKD_UACR%20ms_9AUG2021_clean.pdf. , 2021

Link: https://discovery.ucl.ac..

12

Effects of dapagliflozin on mortality in patients with chro..:

Heerspink, HJL ; Sjöström, CD ; Jongs, N...
https://discovery.ucl.ac.uk/id/eprint/10126060/1/ehab094.pdf. , 2021

Link: https://discovery.ucl.ac..

13

Effect of Dapagliflozin on Clinical Outcomes in Patients wi..:

McMurray, JJV ; Wheeler, DC ; Stefánsson, BV...
https://discovery.ucl.ac.uk/id/eprint/10116358/1/CIRCULATIONAHA.120.051675.pdf. , 2021

Link: https://discovery.ucl.ac..

14

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease:

Chertow, GM ; Vart, P ; Jongs, N...
https://discovery.ucl.ac.uk/id/eprint/10140986/1/Wheeler_JASN-2021-02-0167.R2_AAM.pdf. , 2021

Link: https://discovery.ucl.ac..

15

Safety and efficacy of dapagliflozin in patients with focal..:

Wheeler, DC ; Jongs, N ; Stefansson, BV...
https://discovery.ucl.ac.uk/id/eprint/10140531/1/gfab335.pdf. , 2021

Link: https://discovery.ucl.ac..